Skip to main content
At What Price: Determining Pharmaceutical Prices in Medicare
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • En-US
  • descriptions off, selected
  • captions off, selected
      Events •

      At What Price: Determining Pharmaceutical Prices in Medicare

      A complex array of government policies and market forces cause drug prices to be higher in the United States than other nations. Is this a problem? If so, are there better policies for determining drug prices? What is the “right” price for a drug? Panelists will discuss evidence suggesting that US drug prices are excessive and what policymakers should and should not do in response.

      Featuring
      Pragya Kakani
      Pragya Kakani

      Assistant Professor of Population Health Sciences, Weill Cornell Medical School

      Luca Maini cropped
      Luca Maini

      Assistant Professor of Health Care Policy, Harvard Medical School